Nanoparticles - a historical perspective

被引:305
作者
Kreuter, Joerg [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmazeut Technol, Biozentrum, D-60439 Frankfurt, Germany
关键词
nanoparticles; historical development; DRUG-CARRIER PROPERTY; MICROSPHERE-ENTRAPPED; 5-FLUOROURACIL; MAGNETIC ALBUMIN MICROSPHERES; BLOOD-BRAIN-BARRIER; BODY DISTRIBUTION; POLYALKYLCYANOACRYLATE NANOPARTICLES; INCREASED EFFICIENCY; TISSUE DISTRIBUTION; DELIVERY SYSTEMS; YOSHIDA SARCOMA;
D O I
10.1016/j.ijpharm.2006.10.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The historical development of nanoparticles starting with Paul Ehrlich and then first attempts by Ursula Scheffel and colleagues and the extensive work by the group of Professor Peter Speiser at the ETH Zurich in the late 1960s and early 1970s are described from a personal point of view. Special attention is given to the years between 1970 and the early 1980s. Further developments resulting from this work are also followed, and focus is placed on especially interesting improvements such as nanoparticles for the delivery of drugs across the blood-brain barrier (131313) and PEGylated nanoparticles with a prolonged blood circulation time. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 102 条
[71]   DISPOSITION KINETICS AND ORAL BIOAVAILABILITY OF VINCAMINE-LOADED POLYALKYL CYANOACRYLATE NANOPARTICLES [J].
MAINCENT, P ;
LEVERGE, R ;
SADO, P ;
COUVREUR, P ;
DEVISSAGUET, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (10) :955-958
[72]  
MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
[73]  
MARTY JJ, 1977, THESIS VICTORIAN COL
[74]   PREPARATION AND IN-VITRO EVALUATION OF CELLULOSE-ACETATE PHTHALATE COACERVATE MICROCAPSULES [J].
MERKLE, HP ;
SPEISER, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (09) :1444-1448
[75]   Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain [J].
Michaelis, K. ;
Hoffmann, M. M. ;
Dreis, S. ;
Herbert, E. ;
Alyautdin, R. N. ;
Michaelis, M. ;
Kreuter, J. ;
Langer, K. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03) :1246-1253
[76]   DISTRIBUTION AND ELIMINATION OF POLY(METHYL METHACRYLATE NANOPARTICLES AFTER PERORAL ADMINISTRATION TO RATS [J].
NEFZGER, M ;
KREUTER, J ;
VOGES, R ;
LIEHL, E ;
CZOK, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (09) :1309-1311
[77]  
Oppenheim R. C., 1978, AUST J PHARM, V6, P65
[78]   SOLID COLLOIDAL DRUG DELIVERY SYSTEMS - NANOPARTICLES [J].
OPPENHEIM, RC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1981, 8 (03) :217-234
[79]   Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting [J].
Peracchia, MT ;
Fattal, E ;
Desmaële, D ;
Besnard, M ;
Noël, JP ;
Gomis, JM ;
Appel, M ;
d'Angelo, J ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (01) :121-128
[80]  
Peracchia MT, 1997, J BIOMED MATER RES, V34, P317, DOI 10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO